Key result
Metabolic screening identified a metabolic disorder in 22.4% (95% CI 11.4-33.3%) of children referred with cardiomyopathy of unknown origin.
Why the study?
What is the prevalence of metabolic disorders identified by metabolic screening in children with cardiomyopathy of unknown origin?
Cross-Sectional (n=58)
What is the prevalence of metabolic disorders identified by metabolic screening in children with cardiomyopathy of unknown origin?
Metabolic screening in children with cardiomyopathy of unknown origin has a high diagnostic yield (22.4%), which can guide therapeutic strategy and genetic counseling.
No takes yet. Share an insight, caveat, or question.
May support metabolic screening in unexplained pediatric cardiomyopathy; leaves open prospective validation of yield and outcomes.
Damien Bonnet (1998) conducted a cross-sectional in Childhood cardiomyopathy (n=58). Metabolic screening was evaluated on Prevalence of metabolic disorders (95% CI 11.4-33.3). Metabolic screening identified a metabolic disorder in 22.4% (95% CI 11.4-33.3%) of children referred with cardiomyopathy of unknown origin.
Synapse has enriched one closely related paper. Consider it for comparative context: